<DOC>
	<DOCNO>NCT00999921</DOCNO>
	<brief_summary>The purpose study determine efficacy relapse rate low dose , short duration treatment tamoxifen benign breast disease amenable hormonal therapy respect etiology estrogen receptor status realize side-effects cost therapy . To comparative analysis result even primrose oil one first line management benign breast disease .</brief_summary>
	<brief_title>Effects Tamoxifen Premenopausal Women With Benign Breast Disease Not High-Risk Developing Breast Cancer</brief_title>
	<detailed_description>Benign breast disease frequently encounter female patient , significant proportion premenopausal woman . Established method treatment yield significant result . This social burden also entail high economic cost . As quality life patient matter concern patient family attend physician . Reported effect tamoxifen benign breast disease premenopausal non high risk patient scarce . Moreover publish data yet reveal association estrogen receptor different benign breast lesions.The variability response relation estrogen receptor status still field active investigation .</detailed_description>
	<mesh_term>Breast Diseases</mesh_term>
	<mesh_term>Fibroadenoma</mesh_term>
	<mesh_term>Mastodynia</mesh_term>
	<mesh_term>Fibrocystic Breast Disease</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<mesh_term>Efamol</mesh_term>
	<criteria>Clinical , Radiographic Histological diagnosis Benign Breast Disease . Benign Breast disease amenable hormonal therapy . Postmenopausal woman . Premenopausal woman pregnancy contraindication tamoxifen . Girls le 16 year . Very large lesion require surgery cosmesis . High risk breast lesion like epitheliosis , atypia atypical hyperplasia histopathology susceptible lesion prone develop malignancy . Lesions like duct ectasia hormone therapy likely benefit . Inflammatory lesion amenable antibiotic therapy surgical drainage treatment . Patients unwilling undergo treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Fibrocystic Breast Disease</keyword>
	<keyword>Fibroadenoma</keyword>
	<keyword>Mastalgia</keyword>
</DOC>